[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100396101":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":19,"locations":24,"responsibleParty":37,"collaborators":39,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":52,"minAge":53,"maxAge":19,"enrollmentInfo":54,"targetDuration":19,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":19,"overallStatus":64,"whyStopped":19,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Fondation Hôpital Saint-Joseph","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Obvio-19 App","EXPERIMENTAL","If the patient is willing to participate to the trial, his given oral, free, informed and express consent will be collected and traced in his medical file. After enrollment, patients will be sent an invitation via email to download the Obvio-19 mobile app. After downloading the Obvio-19 app, patients will receive instructions as to how they may communicate with the study investigator. Communication may occur through the chat function of the app or live telephone conversations.\n\nPatients must log into the Obvio-19 app daily to complete the questionnaires. The Obvio-19 system is designed to identify responses that indicate the participant is at an increased risk for serious illness or exhibiting serious symptoms, such as coughing up blood. Such patients will be notified by the app of this status and prompted to seek medical attention.",[13],"Other: Obvio-19 app",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Obvio-19 app","As part of this research, the patient must complete questionnaires daily on the Obvio-19 application, one of 5 minutes.\n\nEvaluation of the proportion of patients with COVID-19 infection's symptoms known to be associated with COVID-19 diagnosis (fever, cough, loss of taste and smell, sore throat, muscle pain, diarrhea, fatigue, difficulty eating and drinking and shortness of breath) followed during a period of 6 months.\n\nTo assess the prevalence and course of symptoms of COVID-19 infection of patients followed during a period of 6 months.\n\nTo establish the correlation of the COVID-19 infection with the biological and clinical data of patients from the Oncology cohort of the Groupe hospitalier Paris Saint-Joseph in Paris followed during a period of 6 months.",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Eric Raymond, MD","PRINCIPAL_INVESTIGATOR",[25],{"facility":26,"status":19,"city":27,"state":19,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":19},"Groupe Hospitalier Paris Saint-Joseph","Paris","75014","France","FR",{"type":32,"coordinates":33},"Point",[34,35],2.3488,48.85341,{"lat":35,"lon":34},{"type":38,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[40],{"name":41,"class":42},"ObvioHealth","INDUSTRY","100396101","prospective-cohort-study-to-describe-the-clinical-characteristics-of-covid-19-the-acquired-immune-response-and-the-biological-and-clinical-parameters-of-patients-followed-in-oncology-by-the-saint-joseph-hospital-group-for-a-period-of-6-months-during-the-covid-19-pandemic-100396101",false,"NCT04437719","Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic","Longitudinal Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group, Paris, France for a Period of 6 Months During the COVID-19 Pandemic in 2020","OBVIONCO","Inclusion Criteria:\n\n* Patient over 18 years of age\n* Patient followed in the medical oncology department of Paris Saint-Joseph Hospital Paris in France\n* Patient Having regular access to smartphone and internet sufficient to support study demands\n* French-speaking patient\n* Affiliation to the social security network\n* Willing and able to provide given oral, free, informed and express consent\n\nExclusion Criteria:\n\n* Patients unable or unwilling to perform all requested study tasks\n* Patient under tutorship or curatorship\n* Patient deprived of liberty\n* Pregnant or lactating patient",true,"ALL","18 Years",{"count":55,"type":56},34,"ACTUAL","INTERVENTIONAL",[59],"NA","This registry will allow to evaluate the correlation of the incidence and evolution of associated symptoms of infection of COVID-19 with the biological and clinical parameters in patients followed in Oncology during the COVID-19 pandemic.",[62,63],"Oncology","COVID-19","COMPLETED","2022-06-29",{"date":67,"type":56},"2022-06-30",{"date":69,"type":56},"2020-06-29",{"date":71,"type":56},"2022-06-03",{"name":5,"class":6},1]